Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
---|---|---|---|---|---|
Net Income | -2.71M | -2.92M | -1.28M | -24.03M | -4.64M |
Total Depreciation and Amortization | 17.00K | 17.30K | 17.30K | 28.60K | 21.40K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 157.00K | 530.00K | 259.20K | 20.19M | 379.50K |
Change in Net Operating Assets | 1.86M | 867.80K | -878.80K | 1.42M | -1.83M |
Cash from Operations | -677.60K | -1.51M | -1.88M | -2.39M | -6.06M |
Capital Expenditure | -- | -- | -- | -9.00K | -78.40K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -535.40K | -33.60K |
Cash from Investing | -- | -- | -- | -544.40K | -112.00K |
Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | -378.50K | -498.10K | -574.90K | 0.00 | 0.00 |
Issuance of Common Stock | 0.00 | 500.00K | 2.13M | 0.00 | 26.70K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00 | -20.10K | -378.40K | 0.00 | 0.00 |
Cash from Financing | -293.60K | -14.30K | 925.20K | 0.00 | 21.50K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -971.10K | -1.52M | -955.80K | -2.93M | -6.15M |